ERRγ, a Novel Biomarker, Associates with Pathoglycemia of Endometrial Cancer to Predict Myometrial Invasion
Open Access
- 21 June 2022
- journal article
- research article
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-11
Abstract
We aim to investigate the correlation between the expression of estrogen-related receptor γ (ERRγ) and endometrial cancer (EC) progression and to evaluate the potential of ERRγ as a new biomarker for EC diagnosis. We analyzed the ERRγ expression profile and the correlation with the corresponding clinical characteristics of EC samples from The Cancer Genome Atlas (TCGA), the Clinical Proteomic Tumor Analysis Consortium (CPTAC) databases, and the International Cancer Genome Consortium (ICGC) databases. Immunohistochemical (IHC) analysis was conducted on tissue samples, and enzyme linked immunosorbent assay (ELISA) was used in serum samples to detect the levels of ERRγ. The diagnostic performance of ERRγ proteins was assessed using the receiver operating characteristic (ROC). ERRγ showed notably higher expression in EC tissues than in normal endometrium tissues ( ), which was consistent with the result of TCGA. Overexpression of ERRγ was significantly associated with deep myometrial invasion of EC ( ), and fasting blood glucose (FBG) was higher in EC patients with deep myometrial invasion than in those with superficial myometrial invasion ( ). Further analysis using ELISA showed that the serum ERRγ level was positively correlated with FBG (R = 0.355, ). ERRγ is overexpressed in EC and may be involved in regulating glucose metabolism and promoting myometrial invasion of EC. In addition, the area under the ROC curve (AUC) for ERRγ was 0.834, in distinguishing EC patients from healthy individuals, presented 84.0% and 80.0% sensitivity and specificity, respectively, and serum ERRγ has a good diagnostic performance in distinguishing EC patients from healthy people and may be a promising noninvasive biomarker in EC.Keywords
Funding Information
- Fujian Maternity and Child Health Hospital College of Clinical Medicine for Obstetrics & Gynecology and Pediatrics, Fujian Medical University (YCXM20-01)
This publication has 28 references indexed in Scilit:
- ERRs Mediate a Metabolic Switch Required for Somatic Cell Reprogramming to PluripotencyCell Stem Cell, 2015
- Alterations in cancer cell metabolism: The Warburg effect and metabolic adaptationGenomics, 2015
- The effects of PGC-1α on the proliferation and energy metabolism of malignant endometrial cancer cellsOncoTargets and Therapy, 2015
- Metabolic Syndrome and Risk of Endometrial Cancer in the United States: A Study in the SEER–Medicare Linked DatabaseCancer Epidemiology, Biomarkers & Prevention, 2015
- The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRγ through AKT and ERK1/2European Journal Of Cancer Prevention, 2014
- The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: Prevalence and prognostic significanceGynecologic Oncology, 2014
- Type I and II Endometrial Cancers: Have They Different Risk Factors?Journal of Clinical Oncology, 2013
- Regulation of glycolysis and the Warburg effect by estrogen-related receptorsOncogene, 2012
- Cancer Cell Metabolism: Warburg and BeyondCell, 2008
- Identification of a new class of steroid hormone receptorsNature, 1988